Johansson J
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):161-72. doi: 10.1016/s0925-4439(98)00065-9.
Pulmonary surfactant contains less than 1 wt% of the very non-polar surfactant protein C (SP-C). In most animal species the major form of SP-C is a 35-residue peptide chain which contains two thioester-linked palmitoyl groups, giving a total molecular mass of 4.2 kDa. Several minor variants of SP-C exist, formed from N-terminal truncation, lysine palmitoylation, methionine oxidation and C-terminal esterification. The primary structure is evolutionarily conserved and SP-C appears to be the only constituent which is unique to pulmonary surfactant, indicating important and specific functions. The three-dimensional structure in an aqueous mixed organic solvent determined by NMR spectroscopy revealed one continuous 37 A long alpha-helix encompassing residues 9-34 as the only regular structural element. The central 23 A of the helix contains exclusively aliphatic residues with branched side-chains, mainly valines, and exposes an all-hydrophobic regular surface. The size of the entire helix perfectly matches the thickness of a fluid dipalmitoylphosphatidylcholine membrane, and the all-hydrophobic part of the helix matches the acyl-chain part of such a bilayer. This supports a transmembrane orientation of SP-C in pulmonary surfactant bilayers. In a phospholipid monolayer, the SP-C helix is tilted, thereby maximizing the interactions with the lipid acyl-chains also in this environment. The palmitoylcysteines of SP-C, which are located in the flexibly disordered N-terminal octapeptide segment, appear to be important both for integrity of the alpha-helical structure and for functional properties. Since the conformation of the N-terminal part in a phospholipid environment is not known, the mechanisms whereby the SP-C thioester-linked palmitoyl chains affect structure and function remain to be determined.
肺表面活性物质中极非极性的表面活性蛋白C(SP-C)含量低于1 wt%。在大多数动物物种中,SP-C的主要形式是一条由35个氨基酸残基组成的肽链,其中含有两个硫酯连接的棕榈酰基,总分子量为4.2 kDa。存在几种SP-C的次要变体,它们由N端截短、赖氨酸棕榈酰化、甲硫氨酸氧化和C端酯化形成。其一级结构在进化上是保守的,SP-C似乎是肺表面活性物质唯一特有的成分,表明其具有重要且特定的功能。通过核磁共振光谱法在水性混合有机溶剂中测定的三维结构显示,一个连续的37 Å长的α螺旋包含9至34位残基,是唯一的规则结构元件。螺旋的中心23 Å仅包含带有支链侧链的脂肪族残基,主要是缬氨酸,并暴露一个全疏水的规则表面。整个螺旋的大小与流体二棕榈酰磷脂酰胆碱膜的厚度完美匹配,螺旋的全疏水部分与这种双层膜的酰基链部分匹配。这支持了SP-C在肺表面活性物质双层膜中的跨膜取向。在磷脂单层中,SP-C螺旋倾斜,从而在这种环境中也能最大化与脂质酰基链的相互作用。位于灵活无序的N端八肽段中的SP-C的棕榈酰半胱氨酸,似乎对α螺旋结构的完整性和功能特性都很重要。由于在磷脂环境中N端部分的构象尚不清楚,SP-C硫酯连接的棕榈酰链影响结构和功能的机制仍有待确定。